Skip to Content

ACS Global Inc - Stock Quote AMCY

Rating as of

Morningstar's ACS Global Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

ACS Global Inc's Company Profile

Business Description

ACS Global Inc is evaluating opportunities for the development of new technologies in the medical and cellular therapy industries. It is looking to identify complimentary products and services for American CryoStem human cell and tissue products (hCTPs). The company supports the ongoing research and development efforts of American CryoStem Corporation in their pursuit of FDA approval of its flagship autologous cell therapy product ATCell.

1 Meridian Road, Suite 5
Eatontown, NJ, 07724
T +1 732 747-1007
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings
Fiscal Year End Dec 31, 2022
Stock Type